What is it about?
It is the first time for demonstration that CXCL8 plays an important role in diabetic nephropathy with a model of type 2 diabetes. G31P, a CXCL8 antogonist, has an effect on protection against renal injury caused by diabtets through its anti-inflammatory effect
Featured Image
Perspectives
Our research is very important for prevention and treatment of diabetic nephropathy with a method involved in anti-inflammation.
Siyuan Cui
Read the Original
This page is a summary of: CXCL8 Antagonist Improves Diabetic Nephropathy in Male Mice With Diabetes and Attenuates High Glucose–Induced Mesangial Injury, Endocrinology, April 2017, Endocrine Society,
DOI: 10.1210/en.2016-1781.
You can read the full text:
Contributors
The following have contributed to this page
